The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. - sprookjes - yvandenbroek - TriplyDB

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

http://www.wikidata.org/entity/Q37235371

about

Effectiveness of UNAIDS targets and HIV vaccination across 127 countries.Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa.Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.Collaborative care for the detection and management of depression among adults receiving antiretroviral therapy in South Africa: study protocol for the CobALT randomised controlled trial.Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.Degree of Housing Instability Shows Independent "Dose-Response" With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus.

P2860

Q30400132-C6D7A1A2-A091-4C11-B0C1-201852D1DB2C Q38375965-90FC1B9F-4C4B-4C3A-8535-63DF5D7EB32A Q38605530-1C06C3E7-F0A1-4556-A12D-D42F2F4548CE Q45326055-7546AB29-375E-423E-A835-00C6E70003B6 Q51731801-B7815D57-84A8-40EA-B701-3EEE953AD96F Q51736507-2EA36D05-DB38-4226-8DFB-1E16381541E0 Q52604813-4536F59C-F643-4AB0-B019-E02BE9285511 Q55231381-D711B236-AD0F-4A87-B075-8D5804E023A5

P2860

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

http://www.wikidata.org/entity/Q37235371

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

@en

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

@nl

type

label

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

@en

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

@nl

prefLabel

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

@en

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

@nl

P1433

Q37235371-C1996FC1-4B12-472C-9DCF-EE85E410CCCD

P1476

Q37235371-182090FF-BE79-48C4-9D23-1C4006880359

P2093

Q37235371-0C81FFF6-EC3A-4964-84D8-5407CDAB2EDF

Q37235371-0EFDC30F-97C1-4C12-8A48-FAB3CBDDD068

Q37235371-36B5295B-D7CA-4881-B337-8B9C87FF103B

Q37235371-768A4668-487B-4A29-89E7-BCFB73444CBE

Q37235371-7C0A3B44-8C43-4295-90BF-AE43EBC272D0

P2860

Q37235371-0A5EF4D2-77C2-46B2-AC35-004DEDF2B7A4

Q37235371-0E6298C9-965F-46F4-884D-ECB54CF3938F

Q37235371-16DDAA80-3A52-4D12-981C-A3AAD63CC6FE

Q37235371-28A4FBA2-B4D5-4784-BEE1-5083C5BF28AB

Q37235371-396FD896-3955-45F0-80ED-5E620171CBD4

Q37235371-5ACE4176-9FEF-42E9-A9D9-94EFC8EF4453

Q37235371-79F1F503-2239-4D15-B0AF-57775526102F

Q37235371-812B497C-E682-4DE5-B5A6-8DA3CF368A14

Q37235371-8934A86F-885D-40F3-98E8-C1979250F9A6

Q37235371-9FF31C34-27FE-4203-836F-ABF1262B0590

P304

Q37235371-DB976DE4-9137-48C3-A0B1-01A5223EB40B

P31

Q37235371-BF588EAD-E71E-4742-A02A-1FCCDA610A8F

P356

Q37235371-C6C7F73D-DE1B-4F07-A0B2-DC7F7D43CF48

P407

Q37235371-078E1F19-0F81-4036-BCBF-F57E3471C7AD

P433

Q37235371-65CE3585-9FD1-4A88-8F53-4C28676DF66C

P478

Q37235371-AEE70546-A585-41D0-A7CA-04084BA6618C

P50

Q37235371-39C71F73-C95E-4D4D-83C8-1CBFF39245EA

Q37235371-4867CEA2-530D-4E19-A7B0-F6134D411DCD

Q37235371-C75B54FF-3916-4C5E-B02C-694AA3D6DB0B

Q37235371-CA253AFB-8920-4F30-851B-7F7DC4BB6EC7

Q37235371-EBAF2BA8-3929-4DB3-87F8-B16258E38D36

P577

Q37235371-6F44E7E3-348E-4732-A941-4AA761C8E162

P698

Q37235371-3E28B5E9-51A8-4B35-9B1A-A4AA439F62B8

P921

Q37235371-16C39FD9-54E5-48CA-9ADB-98B5556A3A64

P932

Q37235371-8C9AFDC3-0800-4320-BED1-D115396BFB4D

P356

P1433

Annals of Internal Medicine

P1476

The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.

@en

P2093

A David Paltiel

http://www.w3.org/2001/XMLSchema#string

Andrea L Ciaranello

http://www.w3.org/2001/XMLSchema#string

Emily P Hyle

http://www.w3.org/2001/XMLSchema#string

Ethan D Borre

http://www.w3.org/2001/XMLSchema#string

Stephen C Resch

http://www.w3.org/2001/XMLSchema#string

P2860

Is antiretroviral therapy cost-effective in South Africa?

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.

Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC

The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.

Large disparities in HIV treatment cascades between eight European and high-income countries - analysis of break points

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention

When to start antiretroviral therapy in resource-limited settings.

Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis

P304

325-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/M16-0799

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

165

http://www.w3.org/2001/XMLSchema#string

P50

Linda-Gail Bekker

Milton Weinstein

Rochelle P. Walensky

Kenneth A Freedberg

P577

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27240120

http://www.w3.org/2001/XMLSchema#string

P921

Aafrikaa Kibbaa

P932

5012932

http://www.w3.org/2001/XMLSchema#string